RMI Laboratories

North Wales, United States Founded: 2009 • Age: 17 yrs Acquired By Frontage Laboratories
ADME and DMPK services are provided through mass spectrometry techniques.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About RMI Laboratories

RMI Laboratories is a company based in North Wales (United States) founded in 2009 was acquired by Frontage Laboratories in November 2019. RMI Laboratories operates in a competitive market with competitors including Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.

  • Headquarter North Wales, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of RMI Laboratories

Premium access

Detailed funding history for RMI Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in RMI Laboratories

RMI Laboratories has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.

All
Investor Description Founded Year Domain Location
Early drug development services are provided for pharma firms.
Locked Locked Locked
Premium access

Investor details for RMI Laboratories

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RMI Laboratories

Investments
Premium access

Investment portfolio details for RMI Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - RMI Laboratories

Premium access

Detailed financials for RMI Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Rmi Laboratories Comparisons

RMI Laboratories Primary company
Description
ADME and DMPK services are provided through mass spectrometr...
Location
North Wales, United States
Founded Year
2009
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for RMI Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of RMI Laboratories

RMI Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
In-vitro and in-vivo genetic toxicology screening services are provided.
Locked Locked Locked
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
Locked Locked Locked
Drug development and preclinical services are provided by Tigermed.
Locked Locked Locked
Clinical trial services to biopharma sector are provided.
Locked Locked Locked
Steroids for Duchenne muscular dystrophy treatment are developed.
Locked Locked Locked
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
Premium access

Detailed competitors of RMI Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Rmi Laboratories

Premium access

Complete news archive for RMI Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RMI Laboratories

RMI Laboratories was founded in 2009.

RMI Laboratories is headquartered in North Wales, United States. It is registered at North Wales, Pennsylvania, United States.

RMI Laboratories is a CRO offering in-vitro and in-vivo services for pharmaceutical and biotechnology companies. They specialise in offering ADME and DMPK services through their expertise in mass spectrometry-based techniques. The companies founders have earlier worked with NIH, USDA and Merck in areas of mass spectrometry, drug metabolism, pharmacokinetics and metabolite identification. Their services include discovery quantitation (HRMS and PK analysis), metabolite identification (early discovery soft spot analysis, late discovery cross-species comparison, preclinical animal radiolabelled mass balance studies), combination assays, biologics services (analysis of peptides, proteins and antibodies), and GLP quantitation (for preclinical and clinical studies).

RMI Laboratories's top competitors include PHAXIAM, BioQual and Jade Bioscience.

RMI Laboratories has 1 investor. Key investors include Frontage Laboratories.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available